Long-term follow-up of CALGB (Alliance) 100001: Autologous followed by non-myeloablative allogeneic transplant for multiple myeloma

CALGB (Alliance) 100001 was a phase II study evaluating autologous stem cell transplant (ASCT) followed by non-myeloablative allogeneic stem cell transplant (alloSCT) in patients with multiple myeloma who had received no more than 18 months of prior therapy and had experienced no more than one prior...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Holstein, Sarah A., Suman, Vera J., Owzar, Kouros, Santo, Katelyn, Benson, Don M., Shea, Thomas C., Martin, Thomas, Silverman, Margarida, Isola, Luis, Vij, Ravi, Cheson, Bruce D., Linker, Charles, Anderson, Kenneth C., Richardson, Paul G., McCarthy, Philip L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7371544/
https://ncbi.nlm.nih.gov/pubmed/32325171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.03.028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky